A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia.

ABSTRACT:

SUBMITTER: Wartman LD 

PROVIDER: S-EPMC4888765 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature